Home
About
Portfolio
Meet the Team
News
Contact
Investor Portal

info@chv.vc
50 Braintree Hill Office Park Suite 301 Braintree, MA 02184

Home / Portfolio / Novazyme Pharmaceuticals

Novazyme Pharmaceuticals

Novazyme Pharmaceuticals developed novel enzyme replacement therapies to treat lysosomal storage disorders.

Status

Exited

Acquired By

Genzyme Corp. (NASDAQ: SNY)

CHV Lead

Joshua Phillips

Related News & Links

Genzyme to Acquire Novazyme Pharmaceuticals

August 5, 2005

Let’s Connect.

Sitemap

Home
About
Portfolio
Meet the Team
News
Contact
Investor Portal

About

Catalyst Health Ventures (CHV) is a venture capital fund investing in transformative medical technologies addressing global unmet needs.

Contact

info@chv.vc

Boston Web Design by GoingClear